Recent research has identified several promising PLpro inhibitors, including small molecules and peptides. High-throughput screening and structure-based drug design have been instrumental in discovering these inhibitors. Some compounds have shown potent antiviral activity in cell-based assays and animal models, demonstrating the potential for therapeutic development. Additionally, advancements in computational methods have enabled the prediction and optimization of PLpro inhibitors with improved efficacy and selectivity.
